Panuri Performance Study aims to test a new lab test, the Panuri test, to detect pancreatic ductal adenocarcinoma (PDAC), a common type of pancreatic cancer. The study is looking at how well this test works in finding PDAC in patients who show symptoms like jaundice (yellow skin), stomach or back pain, unexplained weight loss, and other symptoms that might suggest pancreatic cancer. The Panuri test checks urine to find enzymes linked to PDAC, helping doctors decide if more tests like CT or MRI scans are needed. During the study, the results of the Panuri test will not be shared with the participants or doctors. Participants' health records will be reviewed for diagnosis.

• Study involves visiting a clinic for urine testing and lasts around 1.5 months.
• Participants must be 18 or older and show symptoms suggesting pancreatic cancer.
• Participants shouldn't have certain health issues or be in other studies.